Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Xenetic Biosciences (XBIO) Other Non Operating Income (2023 - 2025)

Xenetic Biosciences (XBIO) has disclosed Other Non Operating Income for 3 consecutive years, with $4011.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Non Operating Income rose 166.69% year-over-year to $4011.0, compared with a TTM value of -$1677.0 through Sep 2025, down 186.49%, and an annual FY2024 reading of -$5708.0, down 122.49% over the prior year.
  • Other Non Operating Income was $4011.0 for Q3 2025 at Xenetic Biosciences, up from $1477.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $21122.0 in Q2 2023 and bottomed at -$7243.0 in Q4 2024.
  • Average Other Non Operating Income over 3 years is $2294.4, with a median of $404.0 recorded in 2023.
  • The sharpest move saw Other Non Operating Income plummeted 1892.82% in 2024, then surged 7133.33% in 2025.
  • Year by year, Other Non Operating Income stood at $404.0 in 2023, then tumbled by 1892.82% to -$7243.0 in 2024, then surged by 155.38% to $4011.0 in 2025.
  • Business Quant data shows Other Non Operating Income for XBIO at $4011.0 in Q3 2025, $1477.0 in Q2 2025, and $78.0 in Q1 2025.